Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Medscape CME Activity

Medscape, LLC is pleased to provide online continuing medical education (CME) for selected journal articles, allowing clinicians the opportunity to earn CME credit. In support of improving patient care, these activities have been planned and implemented by Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME credit is available for one year after publication.

Volume 32—2026

Volume 32, Number 1—January 2026

Cover of issue Volume 32, Number 1—January 2026

Medscape CME Activity
Group A Streptococcus Meningitis, United States, 1997–2022 [PDF - 1.23 MB - 11 pages]
P. A. Hawkins et al.

Group A Streptococcus (GAS) causes a variety of diseases in humans but is not widely appreciated as a cause of meningitis. During 1997–2022, ten sites participating in the Active Bacterial Core Surveillance network in the United States identified GAS meningitis cases. We calculated annual incidence and case-fatality rates (CFRs) for 320 of those cases and determined antimicrobial resistance by whole-genome sequencing. Annual incidence of GAS meningitis ranged from 0.02 to 0.07 cases/100,000 persons. Children <1 year of age had the highest average annual incidence, 0.23 cases/100,000 children. GAS meningitis had a higher CFR (19.4%) than meningitis caused by group B Streptococcus, Streptococcus pneumoniae, Neisseria meningitidis, or Haemophilus influenzae. Clindamycin resistance among GAS meningitis isolates increased from 3.2% during 1997–2002 to 17.7% during 2018–2022. Clinicians should be aware that meningitis is an uncommon but severe manifestation of invasive GAS and has a higher CFR than more established meningitis etiologies.

EID Hawkins PA, Chochua S, Prasad N, Okaro JO, Li Y, Martin T, et al. Group A Streptococcus Meningitis, United States, 1997–2022. Emerg Infect Dis. 2026;32(1):29-39. https://doi.org/10.3201/eid3201.250871
AMA Hawkins PA, Chochua S, Prasad N, et al. Group A Streptococcus Meningitis, United States, 1997–2022. Emerging Infectious Diseases. 2026;32(1):29-39. doi:10.3201/eid3201.250871.
APA Hawkins, P. A., Chochua, S., Prasad, N., Okaro, J. O., Li, Y., Martin, T....Gregory, C. J. (2026). Group A Streptococcus Meningitis, United States, 1997–2022. Emerging Infectious Diseases, 32(1), 29-39. https://doi.org/10.3201/eid3201.250871.

Medscape CME Activity
Retrospective Case Series of Ocular Lyme Disease, 1988–2025 [PDF - 1.95 MB - 6 pages]
J. Bellafiore et al.

Reports of ocular manifestations of Lyme disease (LD) are uncommon, and signs and symptoms may be overlooked by physicians. We conducted a retrospective case series of ocular LD reported during 1988–2025. Among 27 published reports in PubMed, we noted that, in 38 cases, the most common ocular manifestation was uveitis, representing 45% of cases, followed by optic neuritis and cranial nerve palsies (including trochlear and abducens). Not all cases met Centers for Disease Control and Prevention surveillance guidelines for LD, given that some case reports were published before the current guidelines. Cases that provided microbiologic proof were 2 anterior uveitis cases, 1 case of anterior uveitis with abducens’s nerve palsy, 1 case of intermediate uveitis, and 1 case of intranuclear ophthalmoplegia. Ocular LD can have a broad variety of manifestations; therefore, physicians should be aware of those manifestations and obtain microbiologic proof for a more definitive diagnosis and epidemiologic value when possible.

EID Bellafiore J, Mahrous A, Gurumurthy V, Capitle E, Schutzer SE. Retrospective Case Series of Ocular Lyme Disease, 1988–2025. Emerg Infect Dis. 2026;32(1):15-20. https://doi.org/10.3201/eid3201.250769
AMA Bellafiore J, Mahrous A, Gurumurthy V, et al. Retrospective Case Series of Ocular Lyme Disease, 1988–2025. Emerging Infectious Diseases. 2026;32(1):15-20. doi:10.3201/eid3201.250769.
APA Bellafiore, J., Mahrous, A., Gurumurthy, V., Capitle, E., & Schutzer, S. E. (2026). Retrospective Case Series of Ocular Lyme Disease, 1988–2025. Emerging Infectious Diseases, 32(1), 15-20. https://doi.org/10.3201/eid3201.250769.

CME Articles by Volume

Page created: October 01, 2025
Page updated: January 29, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
edit_01 ScholarOne Submission Portal
Issue Select
GO
GO

Spotlight Topics

 

 

Get Email Updates

To receive email updates about this page, enter your email address:

file_external